Synthesis of 3,4-Diaminobenzoyl Derivatives As Factor Xa Inhibitors

Jiabin Yang,Guoqiang Su,Yu Ren,Yang Chen

DOI: https://doi.org/10.1016/j.ejmech.2015.06.012

IF: 7.088

2015-01-01

European Journal of Medicinal Chemistry

Abstract:The coagulation factor Xa (FXa) plays a central role in the blood coagulation cascade. Recent studies have shown that FXa is a particularly attractive target for the development of oral antithrombotic agents. In view of the excellent pharmaceutical properties of 1,2-phenylenediamine-based FXa inhibitors and the reported structure activity relationship (SAR) analysis of FXa inhibitors, we designed and synthesized a series of 3,4-diaminobenzoyl-based FXa inhibitors. Intensive SAR studies on this new series led to the discovery of 3,4-dimethoxyl substituted compound 7b. 7b is a highly potent, selective, direct FXa inhibitor with excellent in vivo antithrombotic activity. (C) 2015 Elsevier Masson SAS. All rights reserved.